Sarah Ibrahim

Sarah Ibrahim is the Associate Director for Stakeholder and Global Engagement in the Office of Generic Drugs (OGD)/ Center of Drug Evaluation and Research (CDER) at the U.S. FDA. In this role, She develops OGD strategies to address identified and emerging regulatory challenges in relation to the international nature of the generic drug industry. In collaboration with other CDER and FDA offices, she supports stakeholder engagement concerning issues related to globalization of the generic pharmaceutical supply and harmonization of regulatory approaches for generic drugs.